Sequent Scientific Ltd.

NSE: SEQUENT | BSE: 512529 | ISIN: INE807F01027 |Industry: Pharmaceuticals
|Expensive Star
153.60 -0.65 (-0.42%)
NSE Oct 22, 2020 15:31 PM
Volume: 897.4K

Sequent Scientific Ltd.    
05 Nov 2018
Nirmal Bang Institutional
Sequent Scientific or SSL's revenues at Rs2,517mn in 2QFY19 were above our estimate by 10.1%. API business surprised us during the quarter as it grew 40%/23% YoY/QoQ, respectively. API business growth was driven by improved geography mix, price increase and volume growth. Around 75% of the growth in API was driven by product mix and price increase. Formulations business performance was adversely impacted by currency depreciation, but the fundamentals remain strong...
Sequent Scientific L.. has an average target of 146.33 from 3 brokers.
More from Sequent Scientific Ltd.